Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

K Chin, S DeVries, J Fridlyand, PT Spellman… - Cancer cell, 2006 - cell.com
This study explores the roles of genome copy number abnormalities (CNAs) in breast cancer
pathophysiology by identifying associations between recurrent CNAs, gene expression, and …

Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome

Y Shi, H Zhao, Y Shi, Y Cao, D Yang, Z Li, B Zhang… - Nature …, 2012 - nature.com
Following a previous genome-wide association study (GWAS 1) including 744 cases and
895 controls, we analyzed genome-wide association data from a new cohort of Han Chinese …

[HTML][HTML] Clinical and molecular aspects of breast cancer: Targets and therapies

RLN Godone, GM Leitão, NB Araújo… - Biomedicine & …, 2018 - Elsevier
Breast Cancer is a complex disease characterized by the occurrence of multiple molecular
alterations. Currently, some molecular markers are in use for breast cancer diagnostic …

Coordination of m6A mRNA methylation and gene transcription by ZFP217 regulates pluripotency and reprogramming

F Aguilo, F Zhang, A Sancho, M Fidalgo, S Di Cecilia… - Cell stem cell, 2015 - cell.com
Epigenetic and epitranscriptomic networks have important functions in maintaining the
pluripotency of embryonic stem cells (ESCs) and somatic cell reprogramming. However, the …

Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217

JJ Northey, AS Barrett, I Acerbi… - The Journal of …, 2020 - Am Soc Clin Investig
Women with dense breasts have an increased lifetime risk of malignancy that has been
attributed to a higher epithelial density. Quantitative proteomics, collagen analysis, and …

[HTML][HTML] The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value

PA Cohen, CF Donini, NT Nguyen, H Lincet… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The recently described oncogene ZNF217 belongs to a chromosomal region that is
frequently amplified in human cancers. Recent findings have revealed that alternative …

ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial–mesenchymal transition and invasion

JA Vendrell, A Thollet, NT Nguyen, SE Ghayad, S Vinot… - Cancer research, 2012 - AACR
The Krüppel-like zinc finger protein ZNF217 is a candidate oncogene in breast cancer. In
this study, we showed that high levels of expression of ZNF217 mRNA are associated with …

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers

A Letessier, F Sircoulomb, C Ginestier, N Cervera… - BMC cancer, 2006 - Springer
Background Oncogene amplification and overexpression occur in tumor cells. Amplification
status may provide diagnostic and prognostic information and may lead to new treatment …

[HTML][HTML] Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma

HN Huang, MC Lin, WC Huang, YC Chiang, KT Kuo - Modern Pathology, 2014 - Elsevier
AT-rich interactive domain 1A (ARID1A) is a subunit of switch/sucrose non-fermentable
(SWI/SNF) complex. Recently, alterations of ARID1A gene, phosphatidylinositol 3-kinase …

Prognosis and gene expression profiling of 20q13-amplified breast cancers

C Ginestier, N Cervera, P Finetti, S Esteyries… - Clinical cancer …, 2006 - AACR
Purpose: Amplification of chromosomal region 20q13 occurs in breast cancer but remains
poorly characterized. Experimental Design: To establish the frequency of 20q13 …